GAN-based Denoising for Scan Time Reduction and Motion Correction of 18F FP-CIT PET/CT: A Multicenter External Validation Study
- 1 July 2025
- journal article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (10) , e580-e588
Abstract
Purpose: AI-driven scan time reduction is rapidly transforming medical imaging with benefits such as improved patient comfort and enhanced efficiency. A Dual Contrastive Learning Generative Adversarial Network (DCLGAN) was developed to predict full-time PET scans from shorter, noisier scans, improving challenges in imaging patients with movement disorders. Patients and Methods: 18F FP-CIT PET/CT data from 391 patients with suspected Parkinsonism were used [250 training/validation, 141 testing (hospital A)]. Ground truth (GT) images were reconstructed from 15-minute scans, while denoised images (DIs) were generated from 1-, 3-, 5-, and 10-minute scans. Image quality was assessed using normalized root mean square error (NRMSE), peak signal-to-noise ratio (PSNR), structural similarity index measure (SSIM), visual analysis, and clinical metrics like BPND and ISR for diagnosis of non-neurodegenerative Parkinson disease (NPD), idiopathic PD (IPD), and atypical PD (APD). External validation used data from 2 hospitals with different scanners (hospital B: 1-, 3-, 5-, and 10-min; hospital C: 1-, 3-, and 5-min). In addition, motion artifact reduction was evaluated using the Dice similarity coefficient (DSC). Results: In hospital A, NRMSE, PSNR, and SSIM values improved with scan duration, with the 5-minute DIs achieving optimal quality (NRMSE 0.008, PSNR 42.13, SSIM 0.98). Visual analysis rated DIs from scans ≥3 minutes as adequate or higher. The mean BPND differences (95% CI) for each DIs were 0.19 (−0.01, 0.40), 0.11 (−0.02, 0.24), 0.08 (−0.03, 0.18), and 0.01 (−0.06, 0.07), with the CIs significantly decreasing. ISRs with the highest effect sizes for differentiating NPD, IPD, and APD (PP/AP, PP/VS, PC/VP) remained stable post-denoising. External validation showed 10-minute DIs (hospital B) and 1-minute DIs (hospital C) reached benchmarks of hospital A’s image quality metrics, with similar trends in visual analysis and BPND CIs. Furthermore, motion artifact correction in 9 patients yielded DSC improvements from 0.89 to 0.95 in striatal regions. Conclusions: The DL-model is capable of generating high-quality 18F FP-CIT PET images from shorter scans to enhance patient comfort, minimize motion artifacts, and maintain diagnostic precision. Furthermore, our study plays an important role in providing insights into how imaging quality assessment metrics can be used to determine the appropriate scan duration for different scanners with varying sensitivities.Keywords
This publication has 23 references indexed in Scilit:
- Imaging Procedure and Clinical Studies of [18F]FP-CIT PETNuclear Medicine and Molecular Imaging, 2024
- Deep Learning-Based Feature Extraction from Whole-Body PET/CT Employing Maximum Intensity Projection Images: Preliminary Results of Lung Cancer DataNuclear Medicine and Molecular Imaging, 2023
- Artificial Intelligence Increases the Agreement among Physicians Classifying Focal Skeleton/Bone Marrow Uptake in Hodgkin’s Lymphoma Patients Staged with [18F]FDG PET/CT—a Retrospective StudyNuclear Medicine and Molecular Imaging, 2022
- Automatic Lung Cancer Segmentation in [18F]FDG PET/CT Using a Two-Stage Deep Learning ApproachNuclear Medicine and Molecular Imaging, 2022
- Preparing for the Artificial Intelligence Revolution in Nuclear CardiologyNuclear Medicine and Molecular Imaging, 2022
- Self-supervised PET DenoisingNuclear Medicine and Molecular Imaging, 2020
- Spatial Normalization Using Early-Phase [18F]FP-CIT PET for Quantification of Striatal Dopamine Transporter BindingNuclear Medicine and Molecular Imaging, 2020
- Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET ImagingNuclear Medicine and Molecular Imaging, 2012
- [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophyMovement Disorders, 2001
- [123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degenerationMovement Disorders, 2000